Discover the future of testosterone replacement therapy as we welcome Shalin Shah, the visionary CEO of Marius Pharmaceuticals, who has made the bold leap from an investment background to the forefront of medical innovation. Shalin shares his journey and unveils Kyzatrex, the FDA-approved oral testosterone that promises to change the game by sidestepping the liver toxicity risks associated with earlier oral options. With Kyzatrex’s novel lymphatic absorption method, we showcase why this advan...